GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (FRA:R3I1) » Definitions » Short Percentage of Float

Advanced Oncotherapy (FRA:R3I1) Short Percentage of Float


View and export this data going back to 2018. Start your Free Trial

What is Advanced Oncotherapy Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Advanced Oncotherapy's Short Percentage of Float

For the Medical Devices subindustry, Advanced Oncotherapy's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Oncotherapy's Short Percentage of Float Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Oncotherapy's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Advanced Oncotherapy's Short Percentage of Float falls into.


Advanced Oncotherapy (FRA:R3I1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (FRA:R3I1) » Definitions » Short Percentage of Float
Comparable Companies
LSE:SUN LSE:MHC LSE:RUA LSE:DEMG LSE:POLX LSE:IHC LSE:IUG LSE:BELL ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH ALGN STE XAMS:PHIA XSWX:SOON
Traded in Other Exchanges
N/A
Address
4 Tenterden Street, Third Floor, London, GBR, W1S 1TE
Website
https://www.avoplc.com
Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.

Advanced Oncotherapy (FRA:R3I1) Headlines

No Headlines